Are you above the legal age to view this content in your province/state?

U.S, March 21, 2020 (CANNABISBUSINESSTIMES) From regulators allowing cannabis delivery and curbside sales to dispensaries being deemed “essential” during shutdowns, the industry is adjusting rapidly. This week, Michigan’s governor announced that all licensed cannabis retailers may set up delivery services to...
U.S, March 18, 2020 (ANALYTICALCANNABIS) Cannabidiol (CBD) has gained a reputation as something of a “cure-all.” Its antioxidant, anti-inflammatory, and analgesic properties have seen the cannabinoid, and cannabis itself, become a commonly suggested remedy for all manner of ailments, from chronic pain, to anxiety, and more. Perhaps it’s no...
U.S., September 5, 2019 (GREENENTREPENEUR)- Scientific evidence is beginning to mount that cannabis may prove beneficial in the fight against cancer. The latest comes from a Harvard University study involving cannabis flavonoids and pancreatic cancer. The news comes on the heels of other research the past several years that involves...
U.S, July 21, 2020 (THECANNABISINCESTOR) Last week, the governor of Illinois announced that the state brought in $52 million in tax revenue in the first six months of legal recreational cannabis sales. During that same time period, total marijuana sales amounted to $239 million. The state announced that 25%...
U.S, April 27 (HEMPGAZETTE) A study led by researchers at Syracuse University in the USA looked into the ability of CBD to reduce pain along with placebo effect impact, with interesting results. A placebo is a substance or treatment that has no therapeutic value,...
UNITED KINGDOM, September 02, 2019 (THE BMJ) - How will private clinics start seeing patients who request medical cannabis based products when NHS doctors seem unable to? Elisabeth Mahase investigates. The only thing stopping two private cannabis clinics in London from issuing prescriptions for medical cannabis is the lack of an approval...
U.S, February 21, 2020 (HEMPGAZETTE) It’s looking like Thunderbirds are go for a medical cannabis insomnia product developed by Zelira Therapeutics (ASX:ZLD). In case you’re wondering who Zelira is, you might recognise it by its previous name – Zelda Therapeutics. The name change came...
UNITED STATES, September 03, 2019 (PROACTIVE INVESTORS) - FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) CEO Dr. Raza Bokhari tells Proactive the cannabis company expects to report meaningful medical cannabis sales revenue in 3Q. Dr. Bokhari says last week, the company reported modest 2Q earnings generated mostly from rental leases. Now, Dr. Bokhari...
U.S, May, 2019 (GRAND VIEW RESEARCH)- The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 23.9% during the forecast period. Increasing legalization and...
ARIZONA, September 12, 2019 (NEWS FILE CORP) - The Stock Day Podcast welcomed FSD Pharma (OTCQB: FSDDF) ("the Company"), a company focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the development...